No Data
No Data
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH): Its product Huoxiang Zhengqi capsule can be used to treat heatstroke.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) stated on the investor interaction platform on August 7 that the company's product Huoxiang Zhengqi Capsules can be used to treat heatstroke.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH): The company's main traditional Chinese medicine planting involves the raw materials of the company's and its subsidiaries' main products.
Guizhou Sanli Pharmaceutical Co., Ltd. stated on the investor interaction platform on August 7 that the planting of traditional Chinese medicine materials is mainly related to the raw materials involved in the company's main products and its subsidiaries.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH): has already expanded its online business through its subsidiary Xiaoquan Medicine.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) stated on the investor interaction platform on August 7th that the company has established online business through its subsidiary, Xiaoqian Medicine.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH): The company has not yet sold overseas.
Guizhou Sanli Pharmaceutical Co., Ltd. (603439.SH) stated on the interactive platform on August 7th that the company has not yet sold overseas.
Guizhou Sanli Pharmaceutical Co.,Ltd (SHSE:603439) Shares Could Be 20% Below Their Intrinsic Value Estimate
On July 31, A-share lightning rod ︱ Tiancheng Technology: Shareholder Rui Xing Phase II plans to reduce its shareholding in the company by no more than 3%; LBX Pharmacy Chain Joint Stock: Actual controller and chairman Xie Zilong has been detained and inv
Tech company Tiancheng's shareholder Ruixing Phase II plans to reduce their total shareholding by no more than 3% of the company's shares; Guizhou Sanli's controlling shareholder, as well as their consistent action person and shareholders who hold 5% or more of the shares, plan to reduce their total shareholding by no more than 4%; LBX Pharmacy Chain Joint Stock claims that actual controlling person and chairman Xie Zilong has been detained and is under investigation.
No Data